Mylan's Chairman and CEO Robert J. Coury Named 2011 World Class CEO by Southpointe CEO Association

PITTSBURGH-June 17, 2011- Inc. (Nasdaq: MYL) today announced that its Chairman and CEO Robert J. Coury was awarded the 2011 World Class CEO Award from the Southpointe CEO Association during a banquet held yesterday.

After receiving the award Coury said: "I am very grateful to be recognized by the Southpointe CEO Association with this honor. While this award is given to an individual, I believe that it truly reflects the achievements of Mylan's workforce of 17,000 around the world who I have the privilege of working for. Throughout the last four years, Mylan has become a world-class, global organization. This distinction is the result of the hard work of a great many talented and dedicated people, and I am extremely proud to accept this award on their behalf."

Barron P. McCune Jr., Vice Chairman, President & CEO, Community Bank and Chairman of Southpointe CEO Association commented: "Under Robert's leadership, Mylan transformed itself into the global powerhouse it is today. The third largest generic and specialty pharmaceuticals company in the world, Mylan brings a great deal of prestige, economic value and jobs to the region. For these and other reasons, we are very happy to honor Robert with this year's World Class CEO Award."

Mylan has a portfolio of more than 1,000 separate pharmaceutical products sold around the world. In the U.S., one out of every 11 prescriptions dispensed - brand name or generic - is filled with a Mylan product.

Coury was elected to Mylan's board of directors in February 2002, having served since 1995 as a strategic advisor to the company. He became its vice chairman shortly after his election and was made CEO in September 2002. He became Mylan's chairman in May 2009.

Past honorees of the Southpointe CEO Association World Class CEO Award have included Jim Cashman, CEO of Inc., Glen T. Meakem, co-founder of Free Markets Inc.; Thomas Rooney, former president of the Penguins organization; Charles Baily Sr., president and CEO of Baily Insurance Agency; Anthony M. Lombardi, president Emeritus of Monongahela Valley Hospital Inc. and Mon-Vale Health Resources Inc.; Paul O'Neill, former chairman of Alcoa and former U.S. Secretary of the Treasury; Tom Usher, former chairman of U.S. Steel Corp.; and J. Brett Harvey, president and CEO of .

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information about Mylan, please visit www.mylan.com. For more information about generic drugs, please visit www.ChoosingGenerics.com.